ADVERUM BIOTECHNOLOGIES INC's ticker is ADVM and the CUSIP is 00773U108. A total of 95 filers reported holding ADVERUM BIOTECHNOLOGIES INC in Q2 2019. The put-call ratio across all filers is 0.13 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2022 | $9,105,000 | -25.6% | 6,950,000 | 0.0% | 0.17% | -20.2% |
| Q4 2021 | $12,232,000 | -18.9% | 6,950,000 | 0.0% | 0.21% | -12.2% |
| Q3 2021 | $15,082,000 | -38.0% | 6,950,000 | 0.0% | 0.24% | -44.0% |
| Q2 2021 | $24,325,000 | -69.2% | 6,950,000 | -13.1% | 0.42% | -68.9% |
| Q1 2021 | $78,880,000 | -9.0% | 8,000,000 | 0.0% | 1.36% | -8.8% |
| Q4 2020 | $86,720,000 | +5.2% | 8,000,000 | 0.0% | 1.49% | +27.5% |
| Q3 2020 | $82,400,000 | -48.0% | 8,000,000 | +5.5% | 1.17% | -62.6% |
| Q2 2020 | $158,375,000 | +126.7% | 7,585,000 | +6.1% | 3.13% | +32.8% |
| Q1 2020 | $69,856,000 | +15.5% | 7,150,000 | +36.2% | 2.36% | +32.8% |
| Q4 2019 | $60,480,000 | +161.1% | 5,250,000 | +23.5% | 1.78% | +83.9% |
| Q3 2019 | $23,163,000 | -44.3% | 4,250,000 | +21.4% | 0.97% | -32.9% |
| Q2 2019 | $41,615,000 | – | 3,500,000 | – | 1.44% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| BML Capital Management, LLC | 3,915,000 | $5,872,500 | 5.39% |
| Versant Venture Management, LLC | 5,068,233 | $7,602,350 | 4.04% |
| Sonic GP LLC | 2,000,000 | $3,000,000 | 2.91% |
| COMMODORE CAPITAL LP | 10,000,000 | $15,000,000 | 1.75% |
| VR Adviser, LLC | 6,573,300 | $9,859,950 | 1.04% |
| AIGH Capital Management LLC | 1,323,985 | $1,985,977 | 0.94% |
| Newtyn Management, LLC | 1,025,000 | $1,537,500 | 0.38% |
| Worth Venture Partners, LLC | 331,668 | $497,502 | 0.30% |
| Acuitas Investments, LLC | 291,169 | $436,754 | 0.26% |
| Quinn Opportunity Partners LLC | 398,298 | $597,447 | 0.08% |